| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |